It has been shown that breast cancer cells (MDA‐MB231), whose migration and metastatic potential is enhanced by IL‐8, have a significantly reduced potential to form metastases in mice when ERK3 was depleted [36]. The gene discussed is MAPK6; the disease is breast carcinoma.